COMTESS Side Effects

6134349-1 | Cholestasis, Jaundice
on Mar 20, 2009 Male patient from FINLAND , 75 years of age, was diagnosed with parkinsonism and was treated with Comtess (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, jaundice (What is jaundice?). Comtess dosage: 1000 Mg/day. During the same period patient was treated with AMANTADINE HCL (200 Mg/day) (View Amantadine Hcl Review and Amantadine Hcl Label ), CARBIDOPA AND LEVODOPA (200mg/day) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ).

6110562-4 | Asthenia, Diarrhoea, Surgery
Patient was taking Comtess (View Usage). Patient had the following side effects: asthenia, diarrhoea, surgery (What is surgery?) on Mar 02, 2009 from FINLAND Additional patient health information: Male patient , 65 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Comtess dosage: Unk. During the same period patient was treated with STALEVO 100 (4 X 1 (200/100/25mg)) (View Stalevo 100 Review and Stalevo 100 Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), ALLOPURINOL (300 Mg, Unk) (View Allopurinol Review and Allopurinol Label ), XIPAMIDE (View Xipamide Review and Xipamide Label ), MADOPAR (2 X 125 Mg, Afternoon) (View Madopar Review and Madopar Label ), MADOPAR DEPOT (Unk) (View Madopar Depot Review and Madopar Depot Label ). Patient was hospitalized.

6043766-X | Bruxism, Tooth Fracture
Adverse event was reported on Jan 12, 2009 by a Male patient taking Comtess (View Usage) (Dosage: Unk) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: FINLAND , 64 years of age, After Comtess was administered, patient had the following side effects: bruxism, tooth fracture. During the same period patient was treated with AMITRIPTYLINE HCL (10 Mg) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), CABERGOLINE (6 Mg) (View Cabergoline Review and Cabergoline Label ), RASAGILINE (Unk) (View Rasagiline Review and Rasagiline Label ), SINEMET (View Sinemet Review and Sinemet Label ).

5723313-X | Cardiopulmonary Failure, Delusion, Dyspnoea, Hallucination, Hypotension, Muscle Rigidity, Psychotic Disorder
on Apr 25, 2008 Male patient from FINLAND , 57 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Comtess (View Usage). Patient experienced the following unwanted or unexpected effects: cardiopulmonary failure, delusion, dyspnoea, hallucination, hypotension, muscle rigidity, psychotic disorder (What is psychotic disorder?). Comtess dosage: 200 Mg. During the same period patient was treated with LEVODOPA (View Levodopa Review and Levodopa Label ), TRIHEXYPHENIDYL HYDROCHLORIDE (View Trihexyphenidyl Hydrochloride Review and Trihexyphenidyl Hydrochloride Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.


5582957-9 | Dental Caries, Dry Mouth, Gingival Disorder, Prostate Cancer, Tooth Extraction
on Dec 28, 2007 Male patient from FINLAND , 64 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Comtess (View Usage). Patient had the following side effects: dental caries, dry mouth, gingival disorder, prostate cancer (What is prostate cancer?), tooth extraction. Comtess dosage: 200 Mg, Qid. During the same period patient was treated with SINEMET (125 Mg Up To 8 Times/day) (View Sinemet Review and Sinemet Label ), SELEGILINE HCL (5 Mg, Qd) (View Selegiline Hcl Review and Selegiline Hcl Label ), ROPINIROLE HCL (5 Mg, Qid) (View Ropinirole Hcl Review and Ropinirole Hcl Label ).

5549521-9 | Pneumonia
Patient was taking Comtess (View Usage). After Comtess was administered, patient had the following side effects: pneumonia (What is pneumonia?) on Dec 04, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 52 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Comtess dosage: 1 Df, 5qd. During the same period patient was treated with CO CARELDOPA (125 Mg/day) (View Co-careldopa Review and Co-careldopa Label ), CO CARELDOPA (500 Mg/day) (View Co-careldopa Review and Co-careldopa Label ), TEGRETOL XR (200 Mg/day) (View Tegretol-xr Review and Tegretol-xr Label ), OXYBUTYNIN CHLORIDE (10 Mg/day) (View Oxybutynin Chloride Review and Oxybutynin Chloride Label ). Patient was hospitalized.

5522458-7 | Dental Caries, Dry Mouth, Gingival Disorder, Prostate Cancer, Tooth Extraction
Adverse event was reported on Nov 08, 2007 by a Male patient taking Comtess (View Usage) (Dosage: 200 Mg, Qid) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: FINLAND , 64 years of age, Patient experienced the following unwanted or unexpected effects: dental caries, dry mouth, gingival disorder, prostate cancer (What is prostate cancer?), tooth extraction. During the same period patient was treated with SINEMET (125 Mg Up To 8 Times/day) (View Sinemet Review and Sinemet Label ), SELEGILINE HCL (5 Mg, Qd) (View Selegiline Hcl Review and Selegiline Hcl Label ), ROPINIROLE HCL (5 Mg, Qid) (View Ropinirole Hcl Review and Ropinirole Hcl Label ).

5520252-4 | Dental Caries, Dry Mouth, Gingival Disorder, Prostate Cancer, Tooth Extraction
on Nov 08, 2007 Male patient from FINLAND , 64 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Comtess (View Usage). Patient had the following side effects: dental caries, dry mouth, gingival disorder, prostate cancer (What is prostate cancer?), tooth extraction. Comtess dosage: 200 Mg, Qid. During the same period patient was treated with SINEMET (125 Mg Up To 8 Times/day) (View Sinemet Review and Sinemet Label ), SELEGILINE HCL (5 Mg, Qd) (View Selegiline Hcl Review and Selegiline Hcl Label ), ROPINIROLE HCL (5 Mg, Qid) (View Ropinirole Hcl Review and Ropinirole Hcl Label ).

5494200-X | Cardiopulmonary Failure, Delusion, Dyspnoea, Hallucination, Hypotension, Muscle Rigidity, Psychotic Disorder
on Oct 19, 2007 Male patient from FINLAND , 57 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Comtess (View Usage). After Comtess was administered, patient had the following side effects: cardiopulmonary failure, delusion, dyspnoea, hallucination, hypotension, muscle rigidity, psychotic disorder (What is psychotic disorder?). Comtess dosage: 200 Mg. During the same period patient was treated with LEVODOPA (View Levodopa Review and Levodopa Label ), TRIHEXYPHENIDYL HYDROCHLORIDE (View Trihexyphenidyl Hydrochloride Review and Trihexyphenidyl Hydrochloride Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

5488072-7 | Faeces Discoloured
Patient was taking Comtess (View Usage). Patient experienced the following unwanted or unexpected effects: faeces discoloured on Oct 09, 2007 from FINLAND Additional patient health information: Male patient , 78 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Comtess dosage: 1 Df, Qid. During the same period patient was treated with SINEMET CR (1 Df, Qd) (View Sinemet Cr Review and Sinemet Cr Label ), CITALOPRAM HYDROBROMIDE (8 Drp, Qd) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), QUETIAPINE FUMARATE (20 Mg, Qd) (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), GLICLAZIDE (40 Mg, Qd) (View Gliclazide Review and Gliclazide Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

5487740-0 | Faeces Discoloured
Adverse event was reported on Oct 09, 2007 by a Male patient taking Comtess (View Usage) (Dosage: 1 Df, Qid) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: FINLAND , 78 years of age, Patient had the following side effects: faeces discoloured. During the same period patient was treated with SINEMET CR (1 Df, Qd) (View Sinemet Cr Review and Sinemet Cr Label ), CITALOPRAM HYDROBROMIDE (8 Drp, Qd) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), QUETIAPINE FUMARATE (20 Mg, Qd) (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), GLICLAZIDE (40 Mg, Qd) (View Gliclazide Review and Gliclazide Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

5476586-5 | Contusion, International Normalised Ratio Increased, Rectal Haemorrhage
on Sep 26, 2007 Male patient from UNITED KINGDOM , 84 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Comtess (View Usage). After Comtess was administered, patient had the following side effects: contusion, international normalised ratio increased, rectal haemorrhage. Comtess dosage: 200 Mg, Qd. During the same period patient was treated with WARFARIN (NGX) (View Warfarin (ngx) Review and Warfarin (ngx) Label ), MADOPAR (525 Mg/d) (View Madopar Review and Madopar Label ), QUININE SULFATE (View Quinine Sulfate Review and Quinine Sulfate Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), FELODIPINE (5 Unk, Unk) (View Felodipine Review and Felodipine Label ), AMIODARONE HYDROCHLORIDE (200 Unk, Unk) (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ). Patient was hospitalized and became disabled.

4931397-1 | Arthralgia, Blood Creatinine Increased, Blood Urea Increased, C-reactive Protein Increased, Dizziness, Nausea, Rash, Swelling
on Jan 19, 2006 Male patient from FINLAND , 79 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Comtess (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, blood creatinine increased, blood urea increased, c-reactive protein increased, dizziness (What is dizziness?), nausea (What is nausea?), rash (What is rash?), swelling. Comtess dosage: Unk, Unk. During the same period patient was treated with SINEMET CR (Unk, Tid) (View Sinemet Cr Review and Sinemet Cr Label ), WARFARIN (3.5 Mg/d) (View Warfarin Review and Warfarin Label ), LOSARTAN POTASSIUM (50 Mg/d) (View Losartan Potassium Review and Losartan Potassium Label ), ROPINIROLE (12 Mg/d) (View Ropinirole Review and Ropinirole Label ). Patient was hospitalized.

4915192-5 | Arthralgia, Blood Creatinine Increased, Blood Urea Increased, C-reactive Protein Increased, Dizziness, Nausea, Rash, Swelling
Patient was taking Comtess (View Usage). Patient had the following side effects: arthralgia, blood creatinine increased, blood urea increased, c-reactive protein increased, dizziness (What is dizziness?), nausea (What is nausea?), rash (What is rash?), swelling on Jan 19, 2006 from FINLAND Additional patient health information: Male patient , 79 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Comtess dosage: Unk, Unk. During the same period patient was treated with SINEMET CR (Unk, Tid) (View Sinemet Cr Review and Sinemet Cr Label ), WARFARIN (3.5 Mg/d) (View Warfarin Review and Warfarin Label ), LOSARTAN POTASSIUM (50 Mg/d) (View Losartan Potassium Review and Losartan Potassium Label ), ROPINIROLE (12 Mg/d) (View Ropinirole Review and Ropinirole Label ). Patient was hospitalized.